Organometallics
Article
CH3Mes), 20.4 (p-CH3Mes′). 11B NMR (160 MHz, 299 K, CD2Cl2): δ =
−24.2 (ν1/2 ∼ 300 Hz). 11B{1H} NMR (160 MHz, 299 K, CD2Cl2): δ
= −24.2 (ν1/2 ∼ 200 Hz). 19F NMR (470 MHz, 299 K, CD2Cl2): δ =
−127.2 (m, 2F, o-C6F6), −160.8 (m, 1F, p-C6F5), −166.4 (m, 2F, m-
C6F5). [Δδ19Fm,p = 5.6]. 31P{1H} NMR (202 MHz, 299 K, CD2Cl2): δ
= 5.7 (ν1/2 ∼ 120 Hz). Anal. Calc. for C34H33FePBF5: C, 64.39; H,
5.24. Found: C, 64.73; H, 4.92. Mp 173 °C.
Preparation of Compound 7. Compound 2 (96 mg, 0.2 mmol)
and HB(C6F6)2 (69 mg, 0.2 mmol) were mixed in pentane (3 mL) and
the resulting solution was stirred for 30 min. The reaction mixture was
filtered and the solvent was removed in vacuo to afford compound 7 as
an orange-red solid. Yield: 148 mg, 90%.
with the ferrocene core is observed as long as the reaction is
performed strictly under a 1:1 stoichiometry. The resulting
phosphine−borane product 7 can be isolated in pure form and
its spectroscopic data as well as the result of X-ray crystal
structure analysis indicate the presence of a non-interacting P/
B frustrated Lewis pair. Not unexpectedly, the ferrocene-
derived P/B FLP 7 is a dihydrogen activator, although the
dihydrogen cleavage reaction shows reversibility. Nevertheless,
the 7/H2 system can be used as a FLP catalyst for the
hydrogenation of a variety of organic π-systems, including a
bulky imine and a couple of bulky enamines. Remarkably, the
7/H2 system can also serve as a catalyst for the selective
hydrogenation of carbon−carbon multiple bonds in a small
series of conjugated enones and ynones, although these
reaction were markedly slower than the above-mentioned
imine or enamine reductions and resulted in only partial
conversions under our typical reaction conditions. The
ferrocene-based FLP 7/H2 catalyst system thus seems to be
suited to tackle both electron-rich as well as electron-poor
organic CN, CC, and CC π-systems under suitable
conditions as a functional main-group element hydrogenation
catalyst.
A comparison of the new ferrocene-based P/B FLP system 7
with our previously reported 1,2-P/B disubstituted FLP system
E (Chart 1)10a revealed the influence of the organometallic
scaffold on the properties of these isomeric compounds.
Whereas compound 7 possesses an open, nonbridged FLP
structure in both the solid state and in solution, its planar-chiral
isomer E shows an equilibrium of open and closed forms at
variable temperature, with the open form, however, strongly
favored at ambient temperature. We found that both the
systems 7 and E are active dihydrogen splitting reagents and
both can serve as hydrogenation catalysts, although the 1,2-
isomer E is more active. Compound 7 needs significantly
forcing conditions for the catalytic hydrogenations (50 bar, 50
°C, 3 d) to proceed satisfactorily, as compared to the previously
reported system E (1.5 bar, r.t., 1 d).
1H NMR (600 MHz, 299 K, Benzene-d6, 7.15 ppm): δ = 6.71 (d,
4JPH = 2.2 Hz, 4H, m-Mes), 4.30 (br s, 2H, Cp-Hβ), 4.17 (br s, 2H, Cp-
Hγ), 3.98 (br s, 2H, Cp-Hβ′), 3.91 (br s, 2H, Cp-Hγ′), 2.41 (s, 12H, o-
CH3Mes), 2.39 (t, 3JHH = 8.0 Hz, 2H, CH2), 2.15 (t, 3JHH = 8.0 Hz, 2H,
BCH2), 2.07 (s, 6H, p-CH3Mes). 13C{1H} NMR (151 MHz, 299 K,
Benzene-d6, 128.0 ppm): δ = 147.0 (dm, 1JFC ∼ 244 Hz, C6F5), 143.4
(dm, 1JFC ∼ 262 Hz, C6F5), 142.5 (d, 2JPC = 15.0 Hz, o-Mes), 137.7 (p-
1
1
Mes), 137.5 (dm, JFC ∼ 255 Hz, C6F5), 132.7 (d, JPC = 20.5 Hz, i-
3
Mes), 130.5 (d, JPC = 3.0 Hz, m-Mes), 114.3 (br m, i-C6F5), 90.8 (i-
Cpα′), 79.8 (d, JPC = 11.8 Hz, i-Cpα), 75.7 (d, JPC = 17.7 Hz, Cpβ),
1
2
71.5 (d, JPC = 4.0 Hz, Cpγ), 69.2 (Cpβ′), 69.0 (Cpγ′), 32.9 (br,
3
BCH2), 24.5 (CH2), 23.5 (d, JPC = 15.2 Hz, o-CH3Mes), 20.8 (p-
3
CH3Mes). 11B{1H} NMR (192 MHz, 299 K, Benzene-d6): δ = 72.9
(ν1/2 ∼ 1500 Hz). 19F NMR (564 MHz, 299 K, Benzene-d6): δ =
3
−130.3 (m, 2F, o-C6F6), −147.0 (t, JFF = 20.9 Hz, 1F, p-C6F5),
−160.9 (m, 2F, m-C6F5). [Δδ19Fm,p = 13.9]. 31P{1H} NMR (243
MHz, 299 K, Benzene-d6): δ = −34.8 (ν1/2 ∼ 2 Hz). Anal. Calc. for
C42H34FePBF10: C, 61.05; H, 4.15. Found: C, 61.14; H, 4.26. Mp 109
°C.
Preparation of Compound 8. (1) Preparation of 9: A freshly
prepared solution of compound 7 in pentane (2 mL), synthesized
from 2 (100 mg, 0.21 mmol) and HB(C6F5)2 (73 mg, 0.21 mmol; see
the procedure above), was added to a solution of triflic acid (30.5 mg,
0.20 mmol) in pentane (1 mL). Immediately, a viscous liquid phase
was formed. After stirring for 5 min at room temperature, the reaction
mixture was cooled down to −30 °C. Then, the viscous mass was
washed with pentane for several times (each 2 mL) until a yellow
powder was obtained. Yield of 9: 169 mg, 84%.
1H NMR (600 MHz, 299 K, CD2Cl2, 5.32 ppm): δ = 8.52 (d, 1JPH
=
4
495.0 Hz, 1H, PH), 7.07 (d, JPH = 3.6 Hz, 4H, m-Mes), 4.92 (s, 2H,
Cp-Hγ), 4.58 (s, 2H, Cp-Hβ), 4.27 (s, 2H, Cp-Hβ′), 4.07 (s, 2H, Cp-
Hγ′), 2.35 (s, 6H, p-CH3Mes), 2.34 (s, 12H, o-CH3Mes), 2.12 (m, 2H,
CH2), 1.54 (m, 2H, BCH2). 13C{1H} NMR (151 MHz, 299 K,
EXPERIMENTAL SECTION
■
For general information, preparative details (including the synthesis of
substrates 1 and 2), and complete spectroscopic and structural data of
1
CD2Cl2, 53.8 ppm): δ = 148.1 (dm, JFC ∼ 240 Hz, C6F5), 146.2 (d,
2
4JPC = 2.3 Hz, p-Mes), 143.3 (d, JPC = 10.6 Hz, o-Mes), 139.3 (dm,
Preparation of Compound 4. Compound 1 (91 mg, 0.2 mmol)
and HB(C6F6)2 (140 mg, 0.4 mmol) were mixed in toluene (3 mL)
and the mixture was stirred for 12 h. Pentane (3 mL) was layered onto
the resulting solution and the mixture was stored at −35 °C to provide
orange crystals and white floe. The obtained mixture was recrystallized
twice with toluene and pentane at −35 °C to yield pure adduct 4.
Yield: 99 mg, 78%.
1JFC ∼ 240 Hz, C6F5), 137.1 (dm, 1JFC ∼ 250 Hz, C6F5), 132.3 (d, 3JPC
1
= 11.3 Hz, m-Mes), 121.9 (br m, i-C6F5), 119.2 (q, JFC = 316.0 Hz,
1
3
CF3), 113.1 (d, JPC = 86.1 Hz, i-Mes), 98.9 (i-Cpα′), 76.2 (d, JPC
=
11.3 Hz, Cpγ), 74.4 (d, 2JPC = 15.0 Hz, Cpβ), 71.0 (Cpβ′), 69.4 (Cpγ′),
59.2 (d, JPC = 99.0 Hz, i-Cpα), 24.6 (br s, BCH2), 24.5 (CH2), 22.2
1
(d, JPC = 8.2 Hz, o-CH3Mes), 21.4 (d, JPC = 1.1 Hz, p-CH3Mes).
11B{1H} NMR (192 MHz, 299 K, CD2Cl2): δ = 6.3 (ν1/2 ∼ 650 Hz).
19F NMR (564 MHz, 299 K, CD2Cl2): δ = −79.2 (s, 3F, CF3), −134.5
3
5
1H NMR (500 MHz, 223 K, CD2Cl2, 5.32 ppm): δ = 7.01 (s, 1H,
m-Mes), 6.81 (s, 1H, m-Mes), 6.57 (s, 1H, m-Mes′), 6.55 (s, 1H, m-
Mes′), 5.28 (s, 1H, Cp-Hβ), 4.57 (s, 1H, Cp-Hγ), 4.49 (s, 1H, Cp-Hγ),
4.09 (s, 5H, C5H5), 4.03 (s, 1H, Cp-Hβ), 3.03 (s, 3H, o-CH3Mes), 2.95
(very br s, 2H, BH2), 2.27 (s, 3H, p-CH3Mes), 2.13 (s, 3H, p-CH3Mes′),
1.68 (s, 3H, o-CH3Mes), 1.58 (s, 3H, o-CH3Mes′), 1.48 (s, 3H, o-
CH3Mes′). 13C{1H} NMR (126 MHz, 223 K, CD2Cl2, 53.8 ppm): δ =
142.6 (d, 2JPC = 16.7 Hz, o-Mes), 141.4 (o-Mes), 140.5 (p-Mes), 140.1
(d, 2JPC = 13.4 Hz, o-Mes′), 139.5 (d, 2JPC = 4.1 Hz, o-Mes′), 139.2 (p-
3
(m, 4F, o-C6F6), −161.3 (t, JFF = 20.3 Hz, 2F, p-C6F5), −166.3 (m,
4F, m-C6F5). [Δδ19Fm,p = 5.0]. 31P{1H} NMR (243 MHz, 299 K,
CD2Cl2): δ = −13.7 (ν1/2 ∼ 11 Hz). 31P NMR (243 MHz, 299 K,
1
CD2Cl2): δ = −13.7 (d, JPH = 495.0 Hz). Anal. Calc. for
C43H35FeO3PSBF13: C, 52.89; H, 3.61. Found: C, 52.20; H, 3.49.
Mp 204 °C.
(2) Preparation of 8: (route a) Neat Et3SiH (60 mg, 5 equiv) was
added to a cooled CH2Cl2 (0.3 mL) solution of compound 9 (97.6
mg, 0.1 mmol) at −30 °C in a small sized vial (2 mL). This vial was
placed into a precooled (−30 °C) bigger vial (10 mL). Then, 2 mL of
precooled (−30 °C) pentane was then added to the bigger vial to
initiate crystallization. After several days, orange-red crystals were
grown from the CH2Cl2/pentane system, which were suitable for X-
ray diffraction analysis. The mixture was filtered to afford the orange-
3
3
Mes′), 131.0 (d, JPC = 7.0 Hz, m-Mes), 130.4 (d, JPC = 10.2 Hz, m-
3
3
Mes), 130.3 (d, JPC = 7.6 Hz, m-Mes′), 129.9 (d, JPC = 9.0 Hz, m-
1
1
Mes′), 125.8 (d, JPC = 56.2 Hz, i-Mes), 125.6 (d, JPC = 51.1 Hz, i-
Mes′), 76.8 (d, 2JPC = 14.2 Hz, Cpβ), 73.7 (d, 2JPC = 2.2 Hz, Cpβ), 72.4
(d, 1JPC = 65.3 Hz, i-Cpα), 72.0 (d, 3JPC = 7.1 Hz, Cpγ), 71.9 (d, 3JPC
=
8.0 Hz, Cpγ), 69.9 (C5H5), 24.7 (o-CH3Mes), 24.4 (d, 3JPC = 4.5 Hz, o-
CH3Mes), 24.0 (o-CH3Mes′), 22.9 (d, 3JPC = 7.2 Hz, o-CH3Mes′), 20.7 (p-
E
Organometallics XXXX, XXX, XXX−XXX